Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Kushwah, Rahul ^a   Gagnon, Stéphane ^b   Sweezey, Neil B ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cystic fibrosis; Na ve T cells; Th17 phenotype

Indexed keywords

ADULT; ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL LINEAGE; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH0 CELL; TH1 CELL; TH17 CELL; YOUNG ADULT; ADOLESCENT; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; DISEASE MODEL; GENETICS; IN VITRO STUDY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ANIMALS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84890258162     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-138     Document Type: Article

References (33)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073. 10.1126/science.2475911, 2475911.
2. Cutting GR, Kasch LM, Rosenstein BJ, Zielenski J, Tsui LC, Antonarakis SE, Kazazian HH. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature 1990, 346:366-369. 10.1038/346366a0, 1695717.
3. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995, 269:847-850. 10.1126/science.7543698, 7543698.
4. Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO J 1995, 14:2700-2707. 398388, 7540975.
5. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-1191. 10.1056/NEJM199204303261804, 1285737.
6. Chmiel JF, Konstan MW. Inflammation and anti-inflammatory therapies for cystic fibrosis. Clin Chest Med 2007, 28:331-346. 10.1016/j.ccm.2007.02.002, 17467552.
7. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15:194-222. 10.1128/CMR.15.2.194-222.2002, 118069, 11932230.
8. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764. 10.1038/35037627, 11048725.
9. Stockinger B, Veldhoen M, Martin B. Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007, 19:353-361. 10.1016/j.smim.2007.10.008, 18023589.
10. Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007, 292:L519-L528. 2841977, 17071720.
11. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005, 175:404-412. 2849297, 15972674.
12. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011, 184:252-258. 10.1164/rccm.201102-0236OC, 3381840, 21474644.
13. Tiringer K, Treis A, Fucik P, Gona M, Gruber S, Renner S, Dehlink E, Nachbaur E, Horak F, Jaksch P, et al. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2013, 187:621-629. 10.1164/rccm.201206-1150OC, 23306544.
14. Iannitti RG, Carvalho A, Cunha C, De LA, Giovannini G, Casagrande A, Zelante T, Vacca C, Fallarino F, Puccetti P, et al. Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am J Respir Crit Care Med 2013, 187:609-620. 10.1164/rccm.201207-1346OC, 23306541.
15. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by ionophoresis. Pediatr 1959, 23:545-549.
16. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 1995, 182:1591-1596. 10.1084/jem.182.5.1591, 2192213, 7595230.
17. Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, Dalod M, Soumelis V, Amigorena S. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013, 38:336-348. 10.1016/j.immuni.2012.10.018, 23352235.
18. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993, 159:197-207. 10.1016/0022-1759(93)90158-4, 8445253.
19. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91. 10.1038/378088a0, 7477296.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061. 10.1126/science.1079490, 12522256.
21. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133. 10.1016/j.cell.2006.07.035, 16990136.
22. Gregory RJ, Cheng SH, Rich DP, Marshall J, Paul S, Hehir K, Ostedgaard L, Klinger KW, Welsh MJ, Smith AE. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 1990, 347:382-386. 10.1038/347382a0, 1699127.
23. Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, Jefferson DM, McCann JD, Klinger KW, Smith AE, Welsh MJ. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990, 347:358-363. 10.1038/347358a0, 1699126.
24. Chambers CA. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001, 22:217-223. 10.1016/S1471-4906(01)01868-3, 11274928.
25. Tsoukas CD, Landgraf B, Bentin J, Valentine M, Lotz M, Vaughan JH, Carson DA. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. J Immunol 1985, 135:1719-1723.
26. Chan YR, Chen K, Duncan SR, Lathrop KL, Latoche JD, Logar AJ, Pociask DA, Wahlberg BJ, Ray P, Ray A, et al. Patients with cystic fibrosis have inducible IL-17 + IL-22+ memory cells in lung draining lymph nodes. J Allergy Clin Immunol 2013, 131:1117-1129. 10.1016/j.jaci.2012.05.036, 22795370.
27. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886. 10.1084/jem.20030152, 2194145, 14676299.
28. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006, 24:209-226. 10.1146/annurev.immunol.24.021605.090547, 16551248.
29. Mackay CR. Dual personality of memory T cells. Nature 1999, 401:659-660. 10.1038/44309, 10537102.
30. Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax 2013,
31. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, Boule M, Cavaillon JM, Clement A. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2003, 284:L997-1003.
32. Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 2000, 120:518-525. 1905557, 10844532.
33. Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, Goronzy JJ. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012, 18:1518-1524. 10.1038/nm.2963, 3466346, 23023500.